Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AIRM
3401
DELISTED
Air Methods Corp
AIRM
| $666K | ﹤0.01% |
+15,629
| New | +$601K |
2013 Q3
0 quarters
|
|
|
VAR
3402
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
| $665K | ﹤0.01% |
10,149
-1,255
| -11% | -$79.5K |
2013 Q2
1 quarter
|
|
|
INVN
3403
DELISTED
Invensense Inc
INVN
| $664K | ﹤0.01% |
37,679
-34,255
| -48% | -$579K |
2013 Q2
1 quarter
|
|
3404
Manulife Financial
MFC
$71.1B
| $663K | ﹤0.01% |
40,014
+24,851
| +164% | +$424K |
2013 Q2
1 quarter
|
|
|
XONE
3405
DELISTED
The ExOne Company
XONE
| $663K | ﹤0.01% |
+15,562
| New | +$976K |
2013 Q3
0 quarters
|
|
|
HSP
3406
CALL
DELISTED
HOSPIRA INC
HSP
| $663K | ﹤0.01% |
16,900
+1,200
| +8% | +$47.8K |
2013 Q2
1 quarter
|
|
3407
Vanda Pharmaceuticals
VNDA
$280M
| $662K | ﹤0.01% |
60,362
-32,294
| -35% | -$345K |
2013 Q2
1 quarter
|
|
3408
PUT
Liquidity Services
LQDT
$1.35B
| $661K | ﹤0.01% |
19,700
+9,000
| +84% | +$286K |
2013 Q2
1 quarter
|
|
3409
Tenaris
TS
$28.3B
| $661K | ﹤0.01% |
14,131
-26,264
| -65% | -$1.19M |
2013 Q2
1 quarter
|
|
3410
CALL
United Natural Foods
UNFI
$2.75B
| $659K | ﹤0.01% |
9,800
+2,100
| +27% | +$128K |
2013 Q2
1 quarter
|
|
3411
PUT
AES
AES
$10.6B
| $657K | ﹤0.01% |
49,400
+6,100
| +14% | +$78.3K |
2013 Q2
1 quarter
|
|
3412
STMicroelectronics
STM
$51.1B
| $657K | ﹤0.01% |
71,446
+57,122
| +399% | +$509K |
2013 Q2
1 quarter
|
|
|
FCS
3413
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $657K | ﹤0.01% |
47,234
-90,797
| -66% | -$1.19M |
2013 Q2
1 quarter
|
|
3414
PUT
Franco-Nevada
FNV
$46.2B
| $656K | ﹤0.01% |
+14,500
| New | +$617K |
2013 Q3
0 quarters
|
|
3415
Comstock Resources
CRK
$3.75B
| $655K | ﹤0.01% |
8,236
-347,228
| -98% | -$27.8M |
2013 Q2
1 quarter
|
|
3416
PUT
Enovis
ENOV
$1.02B
| $655K | ﹤0.01% |
6,740
+1,104
| +20% | +$102K |
2013 Q2
1 quarter
|
|
3417
CALL
TechnipFMC
FTI
$27B
| $654K | ﹤0.01% |
15,859
-8,333
| -34% | -$343K |
2013 Q2
1 quarter
|
|
|
BGC
3418
PUT
DELISTED
General Cable Corporation
BGC
| $654K | ﹤0.01% |
20,600
-16,300
| -44% | -$511K |
2013 Q2
1 quarter
|
|
3419
PUT
Flowers Foods
FLO
$1.18B
| $653K | ﹤0.01% |
30,450
+400
| +1% | +$8.95K |
2013 Q2
1 quarter
|
|
3420
CALL
Meritage Homes
MTH
$4.16B
| $653K | ﹤0.01% |
30,400
+4,800
| +19% | +$103K |
2013 Q2
1 quarter
|
|
3421
CALL
Wolverine World Wide
WWW
$1.58B
| $652K | ﹤0.01% |
22,400
+400
| +2% | +$11.4K |
2013 Q2
1 quarter
|
|
3422
Acadia Pharmaceuticals
ACAD
$3.44B
| $651K | ﹤0.01% |
23,686
-51,573
| -69% | -$1.08M |
2013 Q2
1 quarter
|
|
3423
PUT
O-I Glass
OI
$860M
| $651K | ﹤0.01% |
21,700
+4,000
| +23% | +$119K |
2013 Q2
1 quarter
|
|
|
UTEK
3424
CALL
DELISTED
Ultratech Inc.
UTEK
| $651K | ﹤0.01% |
21,500
+14,100
| +191% | +$432K |
2013 Q2
1 quarter
|
|
|
EPB
3425
CALL
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
| $650K | ﹤0.01% |
15,400
-5,100
| -25% | -$215K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.